PORT-01 · Portfolio & Allocation

Risk Parity

Risk Parity allocates weights so each asset contributes equally to total portfolio risk. Uses inverse volatility as a simple approximation, with optional covariance adjustment.

PortfolioRisk ParityOptimization

At a glance

Best onMulti-asset diversification
Signal frequencyDaily
Typical holding periodMonths
Asset classesIndex, Commodity, FX
Markets tested1
Data through2026-11-10

What the backtest shows

  • Beat buy-and-hold on 0 of 1 markets by annual return over 5 years.
  • Had a smaller maximum drawdown than buy-and-hold on 1 of 1 markets.
  • Best market by Sharpe ratio: RISK-PARITY (Sharpe 1.04, CAGR 8.2%).

Equity curve

0.701.171.632.102.57 201020122014201620182020202220242026
Risk Parity Equal-weight basket · RISK-PARITY, 2010-01-04 → 2026-11-10, growth of 1

Score and risk profile

Arena Score: 54.9RISK-PARITY, 5 years
Return quality · 30%50
Drawdown control · 25%50
Consistency · 20%50
Robustness · 15%50
Significance · 10%99

Each bar is a percentile against every strategy on the same market and window (100 = best).

How it held up in sell-offs (RISK-PARITY)

PeriodStrategyBuy & hold
Q4 2018 sell-off-8.2%-15.9%
COVID crash (Feb–Mar 2020)-13.9%-26.0%
2022 bear market-11.3%-4.4%
Market above its 200-day average (annualized) · 69%+4.0%+6.9%
Market below its 200-day average (annualized) · 31%+4.0%+1.7%

Sell-off dates follow the US stock market. Above/below the 200-day average uses the previous day's position, so there is no look-ahead.

Out-of-sample check (RISK-PARITY)

CheckValue
Chosen parameters on their 3-year training windows (average Sharpe)0.44
Same parameters in the following 6 months, when traded (Sharpe)0.52
Default parameters over the same months (Sharpe)0.52
Parameter re-selections / changes28 / 4
Parameter settings with a positive Sharpe (full history)3 of 3
Sharpe across settings: worst / median / best0.52 / 0.52 / 0.53

Out-of-sample periods start on 2013-01-04. Training-window figures are flattered by picking the best of 3 settings; the out-of-sample figure is what the strategy actually earned. A large drop, or a result that depends on one setting, points to overfitting. How walk-forward testing works.

Results by market (5 years)

MarketCAGRBuy & hold CAGRSharpeMax drawdownBuy & hold max DDVolatilityArena Score
RISK-PARITYRisk Parity8.2%13.8%1.04-15.5%-16.5%7.9%55

Strategy metrics use daily returns without trading costs. Buy-and-hold figures are for the same market and window. Rows are sorted by Sharpe ratio.

RISK-PARITY across time windows

WindowTotal returnCAGRSharpeSortinoMax DDWin daysTrades
1 year+9.4%9.4%1.522.11-5.6%54%12
3 years+48.0%14.0%1.812.64-6.1%58%36
5 years+48.6%8.2%1.041.53-15.5%55%60
Full history+94.0%4.0%0.520.69-28.4%53%204

Rules

Entry

Weight proportional to 1/volatility
Normalize to sum to 1

Exit

Monthly rebalance

Indicators

Rolling volatility
Correlation matrix

Inputs

Lookback = 60
Rebalance = Monthly

Risk

Equal risk contribution target

Strategy evidence

Only available, validated bundles appear below. Missing evidence is not a passing validation result.

Evidence coverage

1 / 1 declared strategy–market pairs validated

Notes

  • Classic risk parity uses inverse volatility
  • More sophisticated versions use covariance matrix
  • Popularized by Bridgewater's All Weather

Related strategies

Embed this score

Add the live badge to a blog post, README or forum signature. It updates with the daily data.

<a href="https://quantarenas.com/strategy/port-01-risk-parity/"><img src="https://quantarenas.com/badge/port-01-risk-parity.svg" alt="Risk Parity Arena Score on Quant Arena" height="20"></a>
[![Risk Parity Arena Score](https://quantarenas.com/badge/port-01-risk-parity.svg)](https://quantarenas.com/strategy/port-01-risk-parity/)

Backtests are historical simulations on daily data and do not include commissions or slippage. They do not guarantee future results and are not investment advice. See the methodology for how every strategy is tested.

Get the weekly Arena report

One email a week: ranking changes, new signals and new research. No spam; unsubscribe any time.